🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Continuous Renal Replacement Therapy

WISDOM UK: Low Dose-intensity Versus Standard Dose-intensity CRRT in Critically Ill Patients NCT07447791NA1 site📍 London Guy's and St Thomas' NHS Foundation Trust · Tests: low intensity of CRRT, usual intensity of CRRT To Compare the Efficacy and Safety of Using oXiris and M100 During CRRT NCT06440759NA1 site📍 Kubang Kerian Mohd Zulfakar Mazlan, MBBS · Tests: oXiris filter, M100 filter Post-Filter Hematocrit NCT07293936NA1 site📍 Iowa City Gwyndolyn M. Radford · Tests: Calculated Post-Filter Hematocrit, Measured Post-Filter Hematocrit Effect of High Versus Standard Protein Intake in Critically Ill Patients With Acute Kidney Injury Requiring Continuous Renal Replacement Therapy NCT07596043NA1 site📍 Bangkok Chulalongkorn University · Tests: High protein group, Standard protein group Evaluation of Integrated Versus Parallel Connection for Renal Replacement Therapy in ECMO Patients NCT06038162NA12 sites📍 Bordeaux📍 Clermont-Ferrand📍 Dijon Hospices Civils de Lyon · Tests: Parallel connection, Integrated connection Effect of a Furosemide Stress Test-Guided Strategy on Liberation From Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury NCT06229990Phase 41 site📍 Chiang Mai Chiang Mai University · Tests: Furosemide Injection Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator NCT06696235Phase 42 sites📍 Seoul📍 Seoul Samsung Medical Center · Tests: Early initiation of continuous renal replacement therapy, Standard initiation of continuous renal replacement therapy Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT NCT05399537Phase 314 sites📍 Birmingham📍 Los Angeles📍 Los Angeles Vantive Health LLC · Tests: Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory In Vivo Antibiotics Removal During Hemoadsorption Cartridges and Continuous Renal Replacement Therapy in the Intensive Care Unit NCT07230041n/a1 site📍 Milan Niguarda Hospital · Tests: Liquid Chromatography - Tandem Mass Spectrometry Filter Lifespan in Continuous Renal Replacement Therapy NCT05450185n/a5 sites📍 Innsbruck📍 São Paulo📍 Erlangen University Hospital Muenster · Tests: Critically ill patients with continuous renal replacement therapy Analgesia Nociception Index to Explore Autonomic Nervous System in Patients With Continuous Renal Replacement Therapy NCT06285162n/a1 site📍 Bron Hospices Civils de Lyon Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU) NCT07469072Phase 21 site📍 Guangzhou Zhujiang Hospital · Tests: Nafamostat Low-Dose Group, Nafamostat High-Dose Group LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM) NCT06446739NA10 sites📍 Rochester📍 Calgary📍 Edmonton University of Alberta · Tests: Continuous Renal Replacement Therapy (CRRT) Nafamostat Efficacy in Phase 3 Registrational CRRT Study NCT06150742NA10 sites📍 Los Angeles📍 Orlando📍 Detroit Talphera, Inc · Tests: Niyad (nafamostat mesylate), Placebo (0.9% NaCl) Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury NCT07236463Phase 1, Phase 22 sites📍 Nîmes📍 Nîmes Centre Hospitalier Universitaire de Nīmes · Tests: Continuous veino-veinous dialysis with iron-chelator supplemented dialysate Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy NCT07346118NA2 sites📍 Bangkok📍 Bangkok Chulalongkorn University · Tests: mVExUS-guided fluid management Validation of a Regional Citrate Anticoagulation Protocol in Critically Ill Patients on Continuous Renal Replacement Therapy NCT07514650NA1 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: continuous renal replacement therapy Optimization of Fluid Balance Guided by Bioelectrical Impedance Analysis in Patients Undergoing Continuous Renal Replacement Therapy in Critical Care NCT06799910NA1 site📍 Salouël Centre Hospitalier Universitaire, Amiens · Tests: continuous renal replacement therapy (CRRT), Free UF Prescription Standard Dose Continuous Renal Replacement Therapy (CRRT) Versus Low-Dose CRRT ( KETZEREI ) NCT06021288NA2 sites📍 Münster📍 Tübingen Universität Münster · Tests: Effluent dose of CRRT Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children NCT04794595n/a1 site📍 Shanghai Children's Hospital of Fudan University · Tests: CBP Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients NCT07643597n/a10 sites📍 Salvador📍 Concepción📍 Los Ángeles Hospital Las Higueras Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy With oXiris Membrane NCT05575024n/a1 site📍 Seoul Seoul National University Hospital · Tests: oXiris membrane, Polysulfone membrane Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients NCT06014801Phase 2, Phase 39 sites📍 Sendai📍 Takatsuki📍 Fukui Jikei University School of Medicine · Tests: Dialysate fluid, Filtration replacement fluid WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department NCT07558265NA6 sites📍 Tucson📍 Ann Arbor📍 Columbus Ohio State University · Tests: Non-Invasive Positive Pressure Ventilation, High Flow Nasal Oxygen Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury NCT05758077NA36 sites📍 Birmingham📍 Phoenix📍 Los Angeles SeaStar Medical · Tests: Selective Cytopheretic Device, Standard of Care OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study NCT07419802n/a1 site📍 Riga Pauls Stradins Clinical University Hospital · Tests: AN69-polyethylenimine hemofilter (Oxiris®) used for continuous veno-venous hemofiltration (CVVH) Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patient NCT06369064NA1 site📍 Nîmes Centre Hospitalier Universitaire de Nīmes · Tests: CVVHD Dialysis parameters, CVVHDF Dialysis parameters Early Endotoxin Burden Reduction With oXiris in Septic Shock Patients Requiring CRRT NCT07807410NA1 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: oXiris Hemofilter Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagulants Using Calcium-containing Replacement Solutions NCT06021080n/a1 site📍 Fuzhou Fujian Provincial Hospital · Tests: CVVH, CVVHD QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry NCT06517810n/a15 sites📍 Birmingham📍 Palo Alto📍 San Francisco SeaStar Medical · Tests: QUELIMMUNE (SCD-PED)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy